Loading: 100%
Edwards Lifesciences Corp logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Irvine, United States of AmericaIrvine, United States of Americano data available
Employees 11,100 (as per Q2 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker EWno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 178090100110120
datesClosing price (adj.)
13.10.2017108.25
11.10.2017110.47
04.10.2017110.22
27.09.2017109.37
20.09.2017111.72
13.09.2017111.78
06.09.2017112.23
30.08.2017112.69
23.08.2017112.71
16.08.2017115.57
09.08.2017116.26
02.08.2017114.24
26.07.2017115.61
19.07.2017119.04
12.07.2017118.44
05.07.2017119.58
27.06.2017117.13
20.06.2017117.87
13.06.2017115.05
06.06.2017116.84
30.05.2017114.60
23.05.2017113.54
16.05.2017113.65
09.05.2017109.99
02.05.2017110.11
25.04.201798.91
18.04.201794.76
11.04.201793.60
04.04.201793.10
28.03.201794.39
21.03.201792.86
14.03.201793.86
07.03.201790.54
28.02.201794.04
21.02.201792.67
14.02.201789.49
07.02.201790.71
31.01.201796.24
24.01.201794.40
17.01.201796.88
10.01.201799.14
03.01.201795.52
27.12.201693.35
19.12.201691.48
12.12.201688.93
05.12.201682.49
28.11.201684.30
21.11.201689.20
14.11.201686.59
07.11.201691.34
31.10.201695.22
24.10.2016117.03
17.10.2016115.55
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
108.25n/a
Market Capitalisation
in million USD
22,858n/a
Enterprise Value
in million USD
22,743n/a
Common Shares Outstanding
as per Jul 24, 2017
211,158,030n/a
Preferred Shares Outstanding
as per Jul 24, 2017
n/a
Average Basic Shares Outstanding
TTM
212,075,000n/a
Average Diluted Shares Outstanding
TTM
217,075,000n/a
Index Membership
n/a
Business Summary
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient\'s diseased or defective heart valve.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 3,232n/a
Gross Profit 2,391n/a
Operating Income 933n/a
EBITDA 1,011n/a
Net Profit 716n/a
Balance Sheet
Cash and Cash Equivalents 1,132n/a
Receivables 0n/a
Total Current Assets 2,283n/a
PP&E 628n/a
Total Assets 5,139n/a
Accounts Payable 563n/a
Current Debt 0n/a
Total Current Liabilities 563n/a
Long-Term Debt 1,017n/a
Total Liabilities 2,199n/a
Total Equity 2,940n/a
Cash Flow
Depreciation & Amortisation 77n/a
Change in Working Capital -143n/a
Operating Cash Flow 733n/a
Net Change in PP&E and Intangibles -189n/a
Investing Cash Flow -403n/a
Dividends Paid 0n/a
Financing Cash Flow -196n/a
Total Change in Cash 138n/a
Free Cash Flow 509n/a
Profitability Ratios
Gross Margin 74.0%n/a
Operating Margin 28.9%n/a
Net Profit Margin 22.2%n/a
Return on Equity 24.4%n/a
Return on Assets 13.9%n/a
Per Share Figures
Basic EPS 3.38n/a
Diluted EPS 3.30n/a
Sales per Share 15.24n/a
Book Value per Share 13.86n/a
FCF per Share 2.40n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 32.05n/a
Price to Sales Ratio 7.10n/a
Price to Book Value 7.81n/a
Price to Free Cash Flow 45.08n/a
Valuation Metrics
EV/EBITDA 22.51n/a
EV/Sales 7.04n/a
Book to Market Value 0.13n/a
Other Ratios
Current Ratio 405.9%n/a
Liabilities to Equity Ratio 74.8%n/a
Debt to Assets Ratio 19.8%n/a
Profit & Loss StatementP&L data quality: 35% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,238
1,321
1,447
1,679
1,900
2,046
2,323
2,494
2,964
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-420
-399
-408
-490
-491
-517
-626
-617
-797
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
818
922
1,039
1,189
1,409
1,529
1,697
1,877
2,166
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-620
-684
-754
-889
-974
-1,118
-464
-1,241
-1,381
Selling, General & Administrative
-481
-509
-550
-642
-683
-795
-118
-858
-937
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-139
-176
-204
-246
-291
-323
-347
-383
-443
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
198
238
284
300
434
411
1,233
636
786
Non-Operating Income (Loss)
-9
3
7
5
-1
-7
-19
-13
-13
Interest Expense, net
-1
-1
-2
0
0
-5
-11
-9
-8
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-8
4
8
5
-2
-1
-8
-4
-5
Pretax Income (Loss), Adjusted
190
241
291
305
433
405
1,215
622
772
Abnormal Gains (Losses)
-25
64
-23
-22
-16
-16
-71
0
-35
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
164
304
268
284
417
388
1,144
622
738
Income Tax (Expense) Benefit, net
-36
-75
-50
-47
-97
-122
-333
-128
-168
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
129
229
218
237
320
266
811
495
570
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
129
229
218
237
320
266
811
495
570
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
129
229
218
237
320
266
811
495
570
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
129
229
218
237
320
266
811
495
570
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 20, 2015 n/a
calculated values,
restated on Feb 19, 2016 n/a
calculated values,
restated on Feb 17, 2017 n/a
calculated values,
restated on Feb 17, 2017 n/a
calculated values,
restated on Feb 17, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
334
396
451
521
937
1,439
1,225
1,271
Cash & Cash Equivalents
n/a
334
396
171
311
420
654
718
930
Short Term Investments
n/a
0
0
279
211
517
785
506
341
Accounts & Notes Receivable
n/a
249
277
284
321
303
288
315
415
Accounts Receivable, Net
n/a
249
277
284
321
303
288
315
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
166
204
261
281
309
297
340
397
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
140
156
173
168
178
208
168
158
Prepaid Expenses
n/a
34
35
35
42
47
49
45
46
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
48
32
44
43
33
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
58
88
94
83
97
159
123
112
Total Current Assets
n/a
889
1,033
1,169
1,292
1,726
2,231
2,048
2,240
Property, Plant & Equipment, Net
n/a
252
270
304
373
422
443
483
580
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
22
25
46
31
29
247
380
532
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
452
440
461
525
533
602
1,146
1,158
Intangible Assets
n/a
0
0
0
0
0
0
0
0
Goodwill
n/a
315
315
350
385
385
376
628
626
Other Intangible Assets
n/a
87
67
67
67
34
23
205
205
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
37
45
20
47
79
154
181
204
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
13
13
25
26
35
49
132
123
Total Noncurrent Assets
n/a
726
735
812
930
984
1,292
2,008
2,270
Total Assets
n/a
1,616
1,767
1,981
2,222
2,710
3,523
4,056
4,510
Liabilities and owners' equity
Payables & Accruals
n/a
291 290500000
296 296000000
335 335200000
347 347400000
346 345600000
426 426100000
476 476200000
533 532500000
Accounts Payable
n/a
255 254600000
274 273700000
320 319800000
347 347400000
346 345600000
426 426100000
476 476200000
533 532500000
Accrued Taxes
n/a
36 35900000
22 22300000
15 15400000
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
0 0
42 41800000
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
291 290500000
338 337800000
335 335200000
347 347400000
346 345600000
426 426100000
476 476200000
533 532500000
Long Term Debt
n/a
90 90300000
0 0
150 150400000
189 189300000
593 593100000
598 598100000
597 596900000
822 822300000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
77 76800000
121 121200000
157 157000000
206 205500000
227 226800000
307 307400000
480 480100000
536 536200000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
77 76800000
121 121200000
157 157000000
206 205500000
227 226800000
307 307400000
480 480100000
536 536200000
Total Noncurrent Liabilities
n/a
167 167100000
121 121200000
307 307400000
395 394800000
820 819900000
906 905500000
1,077 1077000000
1,359 1358500000
Total Liabilities
n/a
458 457600000
459 459000000
643 642600000
742 742200000
1,166 1165500000
1,332 1331600000
1,553 1553200000
1,891 1891000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
1,132 1132100000
328 328300000
421 420500000
613 613200000
797 797200000
1,007 1007300000
1,186 1185900000
1,410 1410400000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-872 -872300000
-102 -102000000
-406 -405800000
-750 -749900000
-1,256 -1256000000
-1,557 -1556900000
-1,837 -1837000000
-2,499 -2499300000
Retained Earnings
n/a
906 906000000
1,124 1124000000
1,361 1360700000
1,654 1653900000
2,031 2030800000
2,842 2841900000
3,337 3336800000
3,906 3906300000
Other Equity
n/a
-8 -7900000
-42 -42100000
-38 -37500000
-38 -37900000
-28 -27600000
-101 -100900000
-183 -182600000
-198 -198400000
Equity Before Minority Interest
n/a
1,158 1157900000
1,308 1308200000
1,338 1337900000
1,479 1479300000
1,544 1544400000
2,191 2191400000
2,503 2503100000
2,619 2619000000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
1,158 1157900000
1,308 1308200000
1,338 1337900000
1,479 1479300000
1,544 1544400000
2,191 2191400000
2,503 2503100000
2,619 2619000000
Total Liabilities & Equity
n/a
1,616 1615500000
1,767 1767200000
1,981 1980500000
2,222 2221500000
2,710 2709900000
3,523 3523000000
4,056 4056300000
4,510 4510000000
Remarks restated on n/a restated on Feb 28, 2011 n/a restated on Feb 27, 2012 n/a restated on Feb 28, 2013 n/a restated on Feb 28, 2014 n/a restated on Feb 20, 2015 n/a restated on Feb 19, 2016 n/a restated on Feb 17, 2017 n/a restated on Jul 28, 2017 n/a
Cash Flow StatementCF data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
129
229
218
237
292
389
811
495
570
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
56
59
57
58
54
63
69
66
71
Non-Cash Items
19
-81
-22
50
-31
-32
-48
-75
-2
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-50
-42
-1
-36
48
53
190
64
66
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
153
165
251
308
362
473
1,022
550
704
Change in Fixed Assets & Intangibles
19
34
-56
-80
-113
-108
-91
-104
-215
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
36
11
0
-293
70
-297
-504
131
20
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
6
2
2
-34
-34
0
-13
-329
2
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-1
-8
-7
1
-2
-8
-26
-14
-19
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
59
40
-62
-407
-79
-413
-633
-316
-212
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
94
-85
-48
104
40
410
-13
2
222
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-243
-29
-108
-244
-244
-451
-188
-193
-559
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
14
22
52
4
49
77
47
32
68
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-134
-92
-104
-135
-156
35
-153
-159
-269
Net Cash Before Disc. Operations and FX
78
114
86
-234
128
95
236
75
224
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
78
114
86
-234
128
95
236
75
224
Effect of Foreign Exchange Rates
-1
2
-24
9
12
15
-3
-10
-13
Net Changes in Cash
77
115
62
-225
140
110
233
65
212
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 20, 2015 n/a
calculated values,
restated on Feb 19, 2016 n/a
calculated values,
restated on Feb 17, 2017 n/a
calculated values,
restated on Feb 17, 2017 n/a
calculated values,
restated on Feb 17, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo